Hutch News

Rethinking why cancer doesn't happen - Part 1

Rethinking why cancer doesn't happen - Part 1

Hutch scientists look beyond DNA to understand how our bodies stop tumors before they start and find new ways prevent cancer
Hutch NewsAugust 15, 2022
Mutated skin stem cells self-correct to prevent cancer

Mutated skin stem cells self-correct to prevent cancer

New study helps explain why inherited cancer-driving mutations don’t always lead to cancer
Hutch NewsJune 12, 2020
Good News at Fred Hutch

Good News at Fred Hutch

Public health researchers get $4 million grant to study aggressive type of colorectal cancer; Core Center of Hematology designated as national core resource
Hutch NewsJuly 30, 2015
Enterovirus D68 seen in cancer, stem cell transplant patients

Enterovirus D68 seen in cancer, stem cell transplant patients

Virus behind outbreak that sickened children also caused illness in immunocompromised adults
Hutch NewsJanuary 16, 2015
Beyond blood drives: Stem cell donors help fuel scientific discovery

Beyond blood drives: Stem cell donors help fuel scientific discovery

Volunteers for the little-known procedures earn up to $800 – and the chance to contribute to cutting-edge research
Hutch NewsOctober 31, 2014
Appelbaum editorial: Evidence tips transplant practice back to bone marrow

Appelbaum editorial: Evidence tips transplant practice back to bone marrow

In New England Journal of Medicine editorial, Fred Hutchinson Cancer Research Center’s Dr. Fred Appelbaum argues adult stem cells harvested from bone marrow rather than blood of unrelated donors are best for reducing graft-vs.-host disease risk
Hutch NewsOctober 22, 2012
Watts' cord blood research garners award

Watts' cord blood research garners award

Kiem Lab's Korashon Watts explores cord blood stem cell expansion; lauded by American Society of Gene & Cell Therapy
Hutch NewsMay 21, 2012
Bradley, Skene win Damon Runyon awards

Bradley, Skene win Damon Runyon awards

Robert Bradley's $100,000 continuation award supports alternative RNA splicing research; Peter Skene's $156,000 grant aids cellular reprogramming efforts
Hutch NewsJanuary 17, 2012
Modified marrow cells may resist chemotherapy’s toxic effects

Modified marrow cells may resist chemotherapy’s toxic effects

Hans-Peter Kiem and colleagues find chemo-resistant genes may enable safer, more effective treatment for brain cancer patients
Hutch NewsMay 23, 2011